TORONTO - Some of the most active companies traded Thursday on the Toronto Stock Exchange and the TSX Venture Exchange:
Toronto Stock Exchange (12,497.94, down 23.09 points):
Lake Shore Gold Corp. (TSX:LSG). Miner. Up 17 cents, or 12.32 per cent, at $1.55 on 11,125,005 shares.
Yellow Media Inc. (TSX:YLO). Directory publisher. Down 1.5 cents, or 7.69 per cent, at 18 cents on 8,119,629 shares. The company announced a shakeup in its board of directors Thursday, bringing in experts in restructuring and corporate finance as it struggles to pay down heavy debt and transition to a digital company.
Manulife Financial Corp. (TSX:MFC). Insurer. Down 23 cents, or 1.90 per cent, at $11.88 on 6,384,311 shares. Canada's largest insurance company said that if low interest rates persist it will likely book a $500-million hit to earnings this year.
Air Canada (TSX:AC.B). Airliner. Down 16 cents, or 12.21 per cent, at $1.15 on 6,343,145 shares.
Grande Cache Coal Corp. (TSX:GCE). Miner. Down one cent, or 0.1 per cent, at $9.7 on 5,000,645 shares.
Kinross Gold Corp. (TSX:K). Miner. Down 13 cents, or 1.18 per cent, at $10.93 on 4,632,208 shares.
TSX Venture Exchange (1,664.82, down 0.92 of a point):
MedX Health Corp. (TSXV:MDX). Life sciences. Up 21 cents, or 466.67 per cent, at 25.5 cents on 12,856,900 shares.
Petromanas Energy Inc. (TSXV:PMI). Oil and gas. Up 2.5 cents, or 8.47 per cent, at 32 cents on 11,574,469 shares.
Companies reporting major news:
Precision Drilling Corp. (TSX:PD). Oil and gas. Up four cents, or 0.35 per cent, at $11.36 on 2,605,425 shares. Canada's largest petroleum field drilling company said it earned a profit of $28 million or 10 cents a share in the fourth quarter of 2011, reversing a loss of $250,000 in the fourth quarter of 2010 as revenue rose to $587 million from $436 million.
Shoppers Drug Mart Corp. (TSX:SC). Pharmaceutical retailer. Up 79 cents, or 1.98 per cent, at $40.64 on 1,820,061 shares. Canada's latest drug store chain raised its dividend after reporting strong sales of non-pharmacy items as it works to reduce its reliance on prescription sales. It also said it expects overall sales to increase between 2.5 and three per cent in 2012.
